跳至主要内容
临床试验/IRCT20190210042676N25
IRCT20190210042676N25招募中2 期

Evaluaion of tolerability and efficacy of Melatrance lightening cream for the treatment of mild to moderate melasma

Knowledge-based company of Janus0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • 18 - 50 years old men and women
  • Cases of mild to moderate melasma (MGSC=1& 2)
  • General health
  • Signing the consent form for participation in the study

排除标准

  • Documented allergies to components of cream
  • Use of topical lightening products like AHA ,BHA and retinoid component within 21 days prior to the study
  • Pregnancy or lactating

研究者

发起方
Knowledge-based company of Janus

相似试验